Netlist Inc
XBER:XAB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Netlist Inc
XBER:XAB
|
US |
|
Checkpoint Therapeutics Inc
F:CZTA
|
US |
|
LendingClub Corp
NYSE:LC
|
US |
|
Red River Bancshares Inc
F:7RR
|
US |
|
K
|
Kangda International Environmental Company Ltd
F:27K
|
CN |
|
Online Blockchain PLC
LSE:OBC
|
UK |
|
A
|
Amada Co Ltd
XBER:AA2
|
JP |
|
Z
|
Zimmer Biomet Holdings Inc
DUS:ZIM
|
US |
|
Medistim ASA
F:MD1
|
NO |
|
B
|
Bilibili Inc
F:71BA
|
CN |
|
B
|
Beiersdorf AG
XMUN:BEI
|
DE |
|
Himadri Speciality Chemical Ltd
NSE:HSCL
|
IN |
|
Exclusive Networks SAS
F:97K
|
FR |
|
E
|
EVRAZ plc
F:EVZ
|
UK |
Wall St Price Targets
XAB Price Targets Summary
Netlist Inc
According to Wall Street analysts, the average 1-year price target for XAB is 0.566 EUR with a low forecast of 0.561 EUR and a high forecast of 0.583 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XAB's stock price target?
Price Target
0.566
EUR
According to Wall Street analysts, the average 1-year price target for XAB is 0.566 EUR with a low forecast of 0.561 EUR and a high forecast of 0.583 EUR.
What is the Revenue forecast for Netlist Inc?
Projected CAGR
35%
Over the last 14 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 2 years is 35%.